Merit Medical Systems, Inc. vs Merck & Company, Inc. — Stock Comparison
Merit Medical Systems, Inc. (MMSI) and Merck & Company, Inc. (MRK) are both listed on US exchanges. This page compares their Q·Score ratings, key fundamentals (P/E, margins, growth), and Wall Street analyst consensus side by side. Data sourced from Yahoo Finance and updated on each page load.
Merit Medical Systems, Inc. narrowly edges Merck & Company, Inc. on Q·Score (7.7 vs 7 out of 10), led by Valuation (9.2 vs 6.7) and Growth (8.1 vs 6.2). Merck & Company, Inc. scores higher on Quality, reflecting stronger profitability and returns. Analyst consensus targets imply greater upside for MMSI (+33.2%) than for MRK (+13.9%).
Price Performance
Normalised to 100 at period start — shows relative performance.
Q·Score Breakdown
Consensus analyst target of $89.55 is 33% above current price.
High-quality business with 19% return on equity and 14% profit margins.
Analyst Consensus
Fundamentals
Frequently Asked Questions
MMSI vs MRK: which stock scores better overall?
Based on Q·Score, Merit Medical Systems, Inc. (MMSI) scores 7.7/10 versus Merck & Company, Inc. (MRK) at 7/10. The Q·Score measures five dimensions: Quality, Health, Growth, Valuation, and Sentiment. For informational purposes only — not financial advice.
Which has better revenue growth: MMSI or MRK?
Merit Medical Systems, Inc. (MMSI) scores higher on Growth (8.1/10 vs 6.2/10). Merit Medical Systems, Inc. reports revenue growth (7.5% YoY) while Merck & Company, Inc. reports (4.9% YoY). Growth scores reflect revenue and earnings momentum relative to sector peers.
Is MMSI or MRK more attractively valued?
Merit Medical Systems, Inc. (MMSI) scores higher on Valuation (9.2/10 vs 6.7/10). MMSI trades at 15.3× P/E versus MRK at 11.9×. Valuation is assessed using P/E ratio, analyst price targets, and 52-week range positioning relative to sector peers.
What do analysts say about MMSI vs MRK?
There are 11 analysts covering MMSI with a consensus price target of $89.55, and 27 analysts covering MRK with a consensus target of $129.74. Analyst consensus ratings are aggregated from Wall Street research and do not constitute investment advice.
Which is more profitable: MMSI or MRK?
Merck & Company, Inc. (MRK) scores higher on Quality (7.7/10 vs 5.7/10). Net profit margin: MMSI at 9.0%, MRK at 13.6%. Quality scores reflect profit margins, return on equity, and free cash flow generation.
Which has stronger financial health: MMSI or MRK?
Merit Medical Systems, Inc. (MMSI) scores higher on Financial Health (8.2/10 vs 7/10). Market beta: MMSI at 0.53, MRK at 0.22. Health scores consider beta, debt-to-equity, and current ratio. All investments carry risk — this is not investment advice.
What are the market caps of MMSI and MRK?
Merit Medical Systems, Inc. (MMSI) has a market capitalisation of $4.0B, while Merck & Company, Inc. (MRK) has a market cap of $281.2B. Market cap data is sourced from Yahoo Finance and reflects the most recent available figures.
Do MMSI or MRK pay dividends?
MMSI does not currently pay a dividend, while MRK pays a dividend yield of 2.95%. Dividend yields fluctuate with share price and company payout decisions.
Related Comparisons
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →